| Patents for C07D 205 - Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom (6,868) |
|---|
| 06/28/2011 | US7968550 Substituted N-aryl heterocycles, process for their preparation and their use as medicaments |
| 06/28/2011 | US7968534 Sulfonamide derivatives, preparation thereof and use thereof as antagonists of orexin 2 receptors |
| 06/23/2011 | WO2011073211A1 Combretastatin derivatives and uses therefor |
| 06/23/2011 | US20110152518 Cycloalkyl Substituted Pyrimidinediamine Compounds And Their Uses |
| 06/23/2011 | US20110152241 Novel compounds as receptor modulators with therapeutic utility |
| 06/22/2011 | EP2336104A1 Ortho-substituted haloalkylsulfonanilide derivative and herbicide |
| 06/22/2011 | EP2102157B1 Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives |
| 06/16/2011 | WO2011071136A1 Therapeutic agent for fibromyalgia |
| 06/16/2011 | WO2011070252A1 Azabicyclo[3.2.0]hept-6-yl derivatives as antagonists of histamine h3 receptor |
| 06/16/2011 | WO2011045703A3 C-linked hydroxamic acid derivatives useful as antibacterial agents |
| 06/16/2011 | US20110144327 Process for the synthesis of azetidinones |
| 06/16/2011 | US20110144326 Method for manufacturing stereoselective preparation of 4-BMA using a chiral auxiliary and chiral auxiliary |
| 06/16/2011 | US20110144082 Compounds for the treatment of peripheral neuropathies |
| 06/14/2011 | USRE42461 Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents |
| 06/14/2011 | US7960433 Treatment of chemokine mediated diseases |
| 06/08/2011 | EP2125714B1 Hydrochloride salt of 5-[3-(3-hydroxyphenoxy)azetidin-1-yl]-5-methyl-2,2- diphenylhexanamide |
| 06/08/2011 | CN1816544B Immunosuppressant compounds and compositions |
| 06/08/2011 | CN102089277A Cyclic amine-1-carboxylic acid ester derivative and pharmaceutical composition containing the same |
| 06/02/2011 | US20110130572 Methods of synthesizing cyclic nitro compounds |
| 06/02/2011 | US20110130378 Ezetimibe process and composition |
| 06/01/2011 | EP2326616A1 Process for the synthesis of ezetimibe and intermediates useful therefor |
| 05/31/2011 | US7951793 Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method |
| 05/25/2011 | EP2324015A2 Thiophene-2-carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 05/25/2011 | EP2323972A1 C7-fluoro substituted tetracycline compounds |
| 05/19/2011 | WO2011057430A1 Chiral n-sulfinyl amino acid amide compounds, preparation method and use thereof |
| 05/19/2011 | US20110118481 Method for preparing azetidine derivatives |
| 05/18/2011 | EP2322505A1 1-adamantylazetidin-2-one derivative and pharmaceutical preparation comprising same |
| 05/18/2011 | EP2321304A2 Therapeutic beta-lactams |
| 05/18/2011 | CN102066318A Process for the preparation of ezetimibe and composition containing it |
| 05/12/2011 | US20110112062 Carbamate And Urea Inhibitors Of 11Beta-Hydroxysteroid Dehydrogenase 1 |
| 05/11/2011 | CN101440056B Method for splitting docetaxel side chain intermediate |
| 05/10/2011 | US7939519 Immunosuppresant compounds and compositions |
| 05/10/2011 | CA2485535C Modified release pharmaceutical formulation |
| 05/05/2011 | WO2011053706A1 4-substituted-2-phenoxy-phenylamine delta opioid receptor modulators |
| 05/05/2011 | WO2011010891A3 Novel post metallocene-type transition metal compound |
| 05/05/2011 | US20110105458 Fatty acid inhibitors |
| 05/05/2011 | US20110105432 Aminocarboxylic acid derivative and medicinal use thereof |
| 05/05/2011 | US20110104043 Instrument and process for nanoparticles production in continuous flow mode |
| 05/05/2011 | CA2779108A1 4-substituted-2-phenoxy-phenylamine delta opioid receptor modulators |
| 05/04/2011 | EP2316830A2 N-sulphonylated amino acid derivatives and their use as matriptase inhibitors |
| 05/04/2011 | EP1867656B1 Compound having cyclic structure and use thereof |
| 04/28/2011 | WO2011019326A3 Solubility and stability enchancing pharmaceutical formulation |
| 04/21/2011 | WO2010141494A3 Synthesis of ezetimibe |
| 04/21/2011 | CA2774250A1 C-linked hydroxamic acid derivatives useful as antibacterial agents |
| 04/20/2011 | EP2311803A1 Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor |
| 04/20/2011 | EP2311802A1 Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor |
| 04/20/2011 | CN101346349B Process for the production of ezetimibe and intermediates used in this proces |
| 04/14/2011 | US20110087010 Anti-angiogenic compounds |
| 04/13/2011 | EP2308812A2 N-acylsulfonamide apoptosis promoters |
| 04/13/2011 | EP2308562A2 Azetidine ring compounds and drugs comprising the same |
| 04/13/2011 | EP2188252B1 1-(4-(4-benzylbenzamido)-benzyl)azetidine-3-carboxylic acid derivatives and related compounds as s1p receptor modulators for the treatment of immune disorders |
| 04/13/2011 | CN102015636A Azetidines and cyclobutanes as histamine H3 receptor antagonists |
| 04/13/2011 | CN102015635A 氮杂环丁烷衍生物 Azetidine derivatives |
| 04/13/2011 | CN102010360A Benzo cyclic chiral diamine |
| 04/13/2011 | CN101115709B Aminocarboxylic acid derivative and medicinal use thereof |
| 04/06/2011 | EP2305640A2 Substituted diphenyl-ethers, -amines, -sulfides and -methanes for the treatment of respiratory diseases |
| 04/06/2011 | EP1934174B1 Azetidines as mek inhibitors for the treatment of proliferative diseases |
| 04/06/2011 | EP1814849B1 Heterocyclic compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor |
| 04/05/2011 | US7919520 Inhibitors of tace |
| 03/31/2011 | US20110077231 Compounds |
| 03/30/2011 | EP2300422A1 Azetidines and cyclobutanes as histamine h3 receptor antagonists |
| 03/30/2011 | CN101993403A Azetidinone compound and medical applications thereof |
| 03/30/2011 | CN101525312B Synthesis method of 3-aza-4-oxo-tricyclo[4.2.1.0(2,5)]non-7-ene |
| 03/30/2011 | CN101402598B Improved method for preparing 1-benzhydryl-3-aza ring butanol |
| 03/24/2011 | WO2011032291A1 Selective calcium channel modulators |
| 03/24/2011 | CA2771612A1 Selective calcium channel modulators |
| 03/23/2011 | EP2212281B1 Arylsulfonamides with analgesic activity |
| 03/22/2011 | US7910609 Inhibitors of integrin alpha2beta1 with modified urea moiety |
| 03/17/2011 | US20110065912 New methods for the preparation of taxanes using chiral auxiliaries |
| 03/16/2011 | EP2294052A1 Process for the preparation of ezetimibe and composition containing it |
| 03/15/2011 | US7906652 Heterocycle-substituted 3-alkyl azetidine derivatives |
| 03/15/2011 | US7906503 Substituted 3-alkyl and 3-alkenyl azetidine derivatives |
| 03/15/2011 | US7906502 2-azetidinone derivatives as cholesterol absorption inhibitors for the treatment of hyperlipidaemic conditions |
| 03/10/2011 | US20110059942 Azetidinyl G-Protein Coupled Receptor Agonists |
| 03/10/2011 | US20110059940 2-Aryl Glycinamide Derivatives |
| 03/10/2011 | US20110059937 Il-8 receptor antagonists |
| 03/08/2011 | US7902181 Compounds 010 |
| 03/08/2011 | US7901893 NPC1L1 (NPC3) and methods of identifying ligands thereof |
| 03/03/2011 | WO2011023667A1 Carbocyclic glyt1 receptor antagonists |
| 03/03/2011 | US20110053908 Azetidine-derived compounds, preparation method therefor and therapeutic use of same |
| 03/03/2011 | US20110053904 Carbocyclic glyt1 receptor antagonists |
| 03/03/2011 | CA2767901A1 Carbocyclic glyt1 receptor antagonists |
| 02/24/2011 | WO2010129057A8 Tetracycline compounds |
| 02/24/2011 | WO2010105267A3 β-LACTAM COMPOUNDS |
| 02/24/2011 | US20110046599 Multi-Day Delivery Of Biologically Active Substances |
| 02/23/2011 | CN101981003A Amide compounds, compositions and uses thereof |
| 02/22/2011 | US7893099 Cyclopentane derivatives |
| 02/22/2011 | US7893048 2-azetidinone derivatives as cholesterol absorption inhibitors for the treatment of hyperlipidaemic conditions |
| 02/17/2011 | WO2011019326A2 Solubility and stability enchancing pharmaceutical formulation |
| 02/17/2011 | WO2011017907A1 Azetidinone compounds and medical use thereof |
| 02/17/2011 | US20110039819 Substituted phenoxybenzamides |
| 02/17/2011 | CA2770793A1 Azetidinone compounds and medical use thereof |
| 02/16/2011 | EP2284166A1 Arylsulfonamides with analgetic activity |
| 02/16/2011 | CN1960727B Naphthalene derivatives useful as histamine-3-receptor ligands |
| 02/15/2011 | US7888354 Phenylpyrazole derivatives |
| 02/15/2011 | CA2460340C Methods and therapeutic combinations for the treatment of xanthoma using sterol absorption inhibitors |
| 02/09/2011 | EP2281899A2 Stereoselective microbial reduction for the preparation of 1-(4-fluorophenyl)-3(R)-3(S)-hydroxy-3-(4-fluorophenyl)propyl)-4(S)-(4-hydroxyphenyl)-2-azetidinone |
| 02/09/2011 | EP1685100B1 Novel 1, 3-disubstituted azetidine derivatives for use as 5ht2a receptor ligands |
| 02/09/2011 | EP1654224B1 Substituted benzoylureido-o-benzoylamides, method for the production thereof and use of the same |
| 02/03/2011 | WO2011012810A1 2-amino-2-phenyl-alkanol derivatives, preparation thereof, and pharmaceutical compositions containing same |